This website is intended for healthcare professionals

Take Pride in your progress

In a year of news about COVID-19, it is easy for a genuinely exciting development like the topic of this month's editorial to get lost in the relentless news cycle of late. I don't think I myself have...

Updates: July 2021

On 10 June, the National Institute for Health and Care Excellence (NICE) published new final guidance that has recommended several new treatment options for around 25 000 people with moderate...

Drug breakdown: Ciprofloxacin

Day 1: A by-product of chloroquine synthesis, quinolone antibiotics were discovered in the early 1960s. Already broad spectrum, the addition of chemical groups such as fluorine led to the 2nd...

The earlier the better: statins to reduce cholesterol and cardiovascular disease

A recently published study evaluated incident cardiovascular disease (CVD) and the initiation as well as subsequent adherence to statin treatment for the treatment of primary prevention in those who...

Statin prescribing, preventative use and lipid levels

This review of the literature published in the Journal of Vascular Health and Risk Management (Reynolds et al, 2021), looked at the important area of the use of the drug group statins and the...

Calculation Skills: keeping it simple

Try the following drug calculations and remember that Sir Isaac Newton [1643-1727] once said ‘Truth [the answer] is ever to be found in the simplicity, and not in the multiplicity and confusion of...

Remote consultations, prescribing and virtual teaching during the COVID-19 pandemic

Before the pandemic, the modernisation of the NHS included digitalisation and the use of remote consultations (NHS UK, 2019; Welsh Government, 2019; NHS Digital, 2020). There had been a slow but...

Calculation Skills: keeping it simple - answers

Drug A is available in 250 microgram tablets. Your patient requires 2 mg twice daily. How many tablets will the patient require each day? .

Small steps, big changes

I suppose I should begin this editorial by letting you know I have now had my second COVID-19 vaccination! I know I am part of a growing number of those afforded increased protection from the virus,...

Updates: May 2021

The National Institute for Health and Care Excellence (NICE) announced on the 4 May 2021 that more people the rare genetic disorder spinal muscular atrophy (SMA) will be able to benefit from...

Drug breakdown: Rivaroxaban

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate.

Exploring the significance of delayed antimicrobial prescribing

In 2016, the National Institute for Health and Care Excellence (NICE) released a quality statement declaring that prescribers in primary care could use delayed prescribing of antimicrobials where they...

Polypharmacy and multimorbidity

This Canadian review paper by Potempski and Bilimoria (2021) aimed to highlight the common phenomenon of polypharmacy in the light of the COVID-19 global pandemic. They begin by pointing out that...

A newly qualified physiotherapist non-medical prescriber in the pandemic

Throughout my training, and as a newly qualified NMP, I was fortunate to work closely with a multidisciplinary team of consultants and nurse specialists in the specialty of rheumatology, all of whom...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP